MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image VELOSBIO INC
VELOSBIO INC

VELOSBIO INC

HQ - San Diego

Summary

VelosBio is a next-generation oncology company, developing novel antibody-drug conjugates to treat haematological cancers.

Deals Overview

Total Deals2
Valued Deals2
Total Value£ 2.22 B
Avg. Deal Size£ 1.11 B

Market Context

Parent Company

PAPPAS CAPITAL

PAPPAS CAPITAL

6 transactions

Sort

08 Jul 2020|United States|Biotechnology
Velosbio
Cormorant Asset Management

Target: VELOSBIO INC

Bidder: CORMORANT ASSET MANAGEMENT

14 Service Providers

2 Target | 12 Bidder

16 Dealmakers

2 Target | 14 Bidder

£ 105 M

Value

05 Nov 2020|United States|Biotechnology
Velosbio
Merck & Co

Target: VELOSBIO INC

Bidder: MERCK & CO

17 Service Providers

4 Target | 4 Bidder | 9 Vendor

55 Dealmakers

20 Target | 9 Bidder | 26 Vendor

£ 2.12 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite